P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas

por Sundov, Dinka, Caric, Ana, Mrklic, Ivana, Gugic, Dijana, Capkun, Vesna, Hofman, Irena Drmic, Mise, Branka Petric, Tomic, Snjezana
Publicado 2013

Olaparib Outcomes in Patients with BRCA 1-2 Mutated, Platinum-Sensitive, Recurrent Ovarian Cancer in Croatia: A Retrospective Noninterventional Study

por Majić, Ana, Miše, Branka Petrić, Matković, Višnja, Belac Lovasić, Ingrid, Katić, Kristina, Canjko, Ivana, Frobe, Ana, Bajić, Žarko, Vrdoljak, Eduard
Publicado 2020

COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study

por Vrdoljak, Eduard, Balja, Melita Perić, Marušić, Zlatko, Avirović, Manuela, Blažičević, Valerija, Tomasović, Čedna, Čerina, Dora, Bajić, Žarko, Miše, Branka Petrić, Lovasić, Ingrid Belac, Flam, Josipa, Tomić, Snježana
Publicado 2021